the benefits of glp-1 drugs beyond obesity Receptor Agonists and Research to Treat Overeating and Substance Use Disorders Photos by Nithin Kamath (@nithinkamath)
Description
Many users find that having food available constantly but eating small amounts works better than scheduled larger meals
Its not FDA-approved for obesity
doi: 10.1038/ejcn.2013.90
intriguingly, although oral semaglutide did not prove superiority over placebo for the primary outcome, it significantly lowered the incidence of death from cardiovascular causes (HR, 0.49
